Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Lam Research | 4.77% | $108.76M | $305.01B | 227.53% | 77 Outperform | |
| Newmont Mining | 3.53% | $80.46M | $134.99B | 196.42% | 81 Outperform | |
| Southern Copper | 3.03% | $69.16M | $174.04B | 139.44% | 73 Outperform | |
| Onto Innovation | 3.03% | $69.06M | $10.99B | 45.97% | 82 Outperform | |
| Medpace Holdings | 2.66% | $60.76M | $12.55B | 29.04% | 79 Outperform | |
| KLA | 2.62% | $59.74M | $197.49B | 121.22% | 77 Outperform | |
| Jazz Pharmaceuticals | 2.38% | $54.30M | $10.56B | 36.53% | 64 Neutral | |
| Regeneron | 2.38% | $54.20M | $81.62B | 11.60% | 78 Outperform | |
| Incyte | 2.22% | $50.62M | $20.11B | 36.62% | 81 Outperform | |
| Monolithic Power | 2.17% | $49.43M | $58.14B | 83.44% | 75 Outperform |